Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04783155 · ClinicalTrials.gov registry record · NA
Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant
A NA study of Post-Lung Transplantation Bronchiectasis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04783155 is a NA study of Post-Lung Transplantation Bronchiectasis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04783155, a NA study of Post-Lung Transplantation Bronchiectasis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.
Conditions Studied
Interventions
- DEVICE POWERBreathe Plus®
- OTHER Cardiopulmonary rehabilitation post lung transplant
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04783155
The ClinicalTrials.gov registry entry for NCT04783155 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-Lung Transplantation Bronchiectasis appearing as the primary indexed condition, and to 2 interventions - of which POWERBreathe Plus® is the first listed.
NCT04783155 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04783155 about?
NCT04783155 is a clinical study titled "Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant". The purpose of this research is to study the effect of training the inspiratory muscles (i.e. the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term clinical outcomes in patients post lung transplant.
What is the current status of trial NCT04783155?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-10. Estimated completion is 2027-12.
What conditions does trial NCT04783155 study?
This clinical trial studies the following conditions: Post-Lung Transplantation Bronchiectasis.
What interventions are being tested in trial NCT04783155?
The interventions under investigation include: POWERBreathe Plus® (DEVICE), Cardiopulmonary rehabilitation post lung transplant (OTHER).
Who is sponsoring clinical trial NCT04783155?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04783155 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-Lung Transplantation Bronchiectasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.